Literature DB >> 19565509

B lymphocyte cytokines and rheumatic autoimmune disease.

Pierre Youinou1, Taher E Taher, Jacques-Olivier Pers, Rizgar A Mageed, Yves Renaudineau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19565509     DOI： 10.1002/art.24665

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

1.  B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis.

Authors:  Susan A Olalekan; Yanxia Cao; Keith M Hamel; Alison Finnegan
Journal:  Eur J Immunol       Date:  2015-02-11       Impact factor: 5.532

Review 2.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 3.  Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.

Authors:  Aurélie De Groof; Patrice Hémon; Olivier Mignen; Jacques-Olivier Pers; Edward K Wakeland; Yves Renaudineau; Bernard R Lauwerys
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Authors:  Pierre Gazeau; Guillermo Carvajal Alegria; Valérie Devauchelle-Pensec; Christophe Jamin; Julie Lemerle; Boutahar Bendaoud; Wesley H Brooks; Alain Saraux; Divi Cornec; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

5.  TNF-α-secreting B cells contribute to myocardial fibrosis in dilated cardiomyopathy.

Authors:  Miao Yu; Shuang Wen; Min Wang; Wei Liang; Huan-Huan Li; Qi Long; He-Ping Guo; Yu-Hua Liao; Jing Yuan
Journal:  J Clin Immunol       Date:  2013-04-05       Impact factor: 8.317

6.  Identification of IL-40, a Novel B Cell-Associated Cytokine.

Authors:  Jovani Catalan-Dibene; Monica I Vazquez; Van Phi Luu; Sean-Paul Nuccio; Alborz Karimzadeh; Jenna M Kastenschmidt; S Armando Villalta; Irina Ushach; Egest J Pone; Paolo Casali; Manuela Raffatellu; Amanda M Burkhardt; Marcela Hernandez-Ruiz; Gina Heller; Peter A Hevezi; Albert Zlotnik
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

Review 7.  How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses.

Authors:  Marina I Arleevskaya; Olga A Kravtsova; Julie Lemerle; Yves Renaudineau; Anatoly P Tsibulkin
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

8.  Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production.

Authors:  William A Rose; Angela J Okragly; Ningjie N Hu; Montanea R Daniels; Andrea P Martin; Yi Ting Koh; Kristine Kikly; Robert J Benschop
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

Review 9.  B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus.

Authors:  Gabriel J Tobón; Jorge H Izquierdo; Carlos A Cañas
Journal:  Autoimmune Dis       Date:  2013-09-26

10.  Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study.

Authors:  Michael Schiff; Bernard Combe; Thomas Dörner; Joel M Kremer; Thomas W Huizinga; Melissa Veenhuizen; Anne Gill; Wendy Komocsar; Pierre-Yves Berclaz; Robert Ortmann; Chin Lee
Journal:  RMD Open       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.